Biopharmaceuticals are drugs produced from genetically modified source, which are mainly proteins and nucleic acids. According to IMS Health Market Prognosis, the total market size of pharmaceutical industry was approximately $962.1 billion in 2012. The market for the biopharmaceuticals drug was $149 billion in 2010. The factors driving the market are, increase in regulatory approvals for biotechnology products. One such product is the recombinant DNA-based products, which has high rates of approval from regulatory authorities. The opportunities of this market are the ageing population and increase in the number of diseases. The challenges of this market are the reimbursement and pricing policy that are the limiting factors in the launch of high priced drugs.
Key player profiled in the report are Pfizer, Inc., Ranbaxy Laboratories Ltd., Roche Holding AG, Abbott Laboratories, Inc., Bayer AG, Biocon Ltd, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline, PLC. Johnson & Johnson, Inc., LG Life Sciences and Novartis AG
KEY MARKET SEGMENTS
SIMILAR MARKET STUDIES
Complete report $3,950. DataPack (test volumes, sales forecasts, supplier shares) $2,500.Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory ...
June 2015 | $2500 | View Details >>
The Binocular market size will be XX million (USD) in 2022 in Germany, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Germany market, the top players include many company. With key sales data like sales (volume), revenue, market share ...
April 2017 | $3360 | View Details >>
Summary This comprehensive report from VPGMarketResearch.com contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years. The report explores market and technological trends; provides reagent, instrument and test volume for 40 coagulation procedures; compares features ...
January 2017 | $0 | View Details >>
Complete report $7,700. DataPack (test volumes, sales forecasts, supplier shares) $4,950. “2014 Analysis of the Japanese Blood Banking Market: Innovations, Trends and Opportunities for Suppliers” is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities ...
November 2013 | $4950 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research